Board Of Directors

Age: 67

Date of appointment as a director: 1 July 2025

Date of last endorsement as a director: N/A

WORK EXPERIENCE

Mr. Hu currently serves as Emeritus Asia Chairman of the Milken Institute, an independent American economic think tank. He is also Chairman of Constellar Holdings Ltd, a Temasek portfolio company in the exhibitions and conventions sector, and Chairman of Mandai Nature, a non-profit foundation committed to biodiversity protection and wildlife conservation in Southeast Asia. He also serves as Singapore's Non-Resident Ambassador to Timor Leste, a position he has held since February 2023, and is expected to conclude in April 2026.

He is also a member of the International Advisory Council of the Official Monetary and Financial Institutions Forum (OMFIF), a London based think tank, and serves on Bank of Singapore's CIO Global Advisory Investment Council.

Previously, Mr. Hu was Vice Chairman Asia and Operating Partner at Temasek, the global investment firm headquartered in Singapore. At Temasek, he led the Sustainability and International Policy groups before assuming the role of Advisory Senior Director in 2024.

Before joining Temasek, Mr. Hu was the Group CEO of the South China Morning Post Group, a Hong Kong listed media company. He oversaw the organisation's transformation into a digitally focused media platform, which culminated in its subsequent divestiture to Alibaba Group.

Mr. Hu has served on several boards, including MediaCorp, Singapore's national broadcaster; Business China, a non-profit organisation promoting business ties between Singapore, ASEAN, and China; and the Bangkok Post Group, listed on the Stock Exchange of Thailand.

With professional experience spanning Singapore, Beijing, Shanghai, Suzhou, Taiwan, and Hong Kong, Mr. Hu has worked across diverse sectors including IT, internet, media, finance, and government. He is an active follower of international affairs and geopolitics.

ACADEMIC & PROFESSIONAL QUALIFICATIONS

• M. Sc. Computer Science and Mathematics, Cardiff University, University of Wales

PRESENT DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS

• Director of Milken Institute Asia Center
• Non-Resident Ambassador to Timor Leste
• Director of Mandai Nature International Ltd.
• Director of Constellar Holdings Pte. Ltd.
• Chairman of Mandai Nature CLG and Mandai Nature IPC
• Director of Mandai Nature Fund Ltd.
• Director of TJ Holdings (III) Pte. Ltd.

PAST DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS HELD OVER THE PRECEDING 3 YEARS

• Director of Business China
• Director of Mediacorp Pte. Ltd.
• Director of Constellar Group Pte. Ltd.
• Director of T-Prep Pte. Ltd.

Age: 64

Date of appointment as a director: 25 October 2024

Date of last endorsement as a director: 21 April 2025

WORK EXPERIENCE

Ms. Goh has been the Founding Director of 360 Dynamics since 1998, and of 360 Dynamics Sdn Bhd since 2013. She advises businesses and leaders through consulting and coaching on purpose, mission and strategy, organisational behaviour and development, as well as the governance frameworks that underpin responsible and sustainable performance. Her work is grounded in helping organisations achieve both business and societal outcomes within complex, interconnected ecosystems undergoing rapid change.

She brings over 20 years of board-level experience in community healthcare governance, having served with SATA CommHealth and the Agency for Integrated Care. In these organisations, she chaired the Governance, Nominating, and Human Resource Committees. She also served as Chair of The Centre for Non-Profit Leadership, which supports more than 2000 non-profit boards in strengthening their capabilities and scaling towards governance excellence.

ACADEMIC & PROFESSIONAL QUALIFICATIONS

• MSC, Organisational Psychology, City University of New York (Baruch College)
• BBA, National University of Singapore
• Senior Accredited Director, Singapore Institute of Directors
• ISCA BOD Masterclass
• ICF Accredited Coach (via Global Coach Group)
• Professional Qualifications on Global Strategic Leadership and Team Leadership, 360 Leadership Assessments, Inclusion, various Personality tools, Relationship Motivators , Values, Change & Influence Style and Competencies

PRESENT DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS

• Appointed Chairperson of Charity Council, Singapore
• Appointed Vice President of National Council for Social Service
• Appointed Member of Chief Justice Panel of Inquiry

PAST DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS HELD OVER THE PRECEDING 3 YEARS

• Chairperson of SATA CommHealth Limited
• Director, Agency for Integrated Care

Age: 67

Date of appointment as a director: 20 October 2025

Date of last endorsement as a director: N/A

WORK EXPERIENCE

Mrs. Eng is a Consultant of Allen & Gledhill LLP, Singapore. She is also an Independent Non-Executive Director of Mapletree Industrial Trust Management Ltd and an Independent Non-Executive Director and a member of Audit & Risk Management Committee of Link Asset Management Limited.

Mrs. Eng has more than 30 years of investment banking experience.

She held the position of Group Head of Capital Markets at DBS Bank Ltd. and was a member of its Group Management Committee prior to her retirement in March 2024. As a senior banker in one of Asia's leading banks with a presence in 19 markets, Mrs. Eng helmed a regional role beyond Singapore and led several teams on advisory and corporate finance as well as the structuring and execution of equity transactions.

Mrs. Eng also oversaw the securities business under DBS Vickers Securities and the capital markets digital business under the DBS Digital Asset Ecosystem. For her outstanding contributions, Mrs. Eng was inducted as an Institute of Banking and Finance Distinguished Fellow.

ACADEMIC & PROFESSIONAL QUALIFICATIONS

• Master of Commerce, University of New South Wales, Australia
• Bachelor of Art, National University of Singapore

PRESENT DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS

• Independent Non-Executive Director of Mapletree Industrial Trust Management Ltd
• Independent Non-Executive Director and member of Audit & Risk Management Committee of Link Asset Management Limited
• Consultant of Allen & Gledhill LLP, Singapore

PAST DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS HELD OVER THE PRECEDING 3 YEARS

• Director of DBS Vickers Securities Holdings Pte Ltd
• Director of DBS Finnovation Pte. Ltd.
• Chairman and Director of DBS Digital Exchange Pte. Ltd.
• Chairman and Director of DBS Vickers (Thailand) Co. Ltd
• Deputy Chairman and Director of DBS Asia Capital Ltd

Age: 50

Date of appointment as a director: 17 November 2023

Date of last endorsement as a director: 30 April 2024

WORK EXPERIENCE

Mr. Tomo Nagahiro was appointed to the Board of IHH in February 2023. He was an alternate director on the Board of IHH from April 2019 to January 2023. Mr. Nagahiro has been appointed as Unit Operating Officer, Consumer-Centric Business Development Unit, Mitsui & Co. (Asia Pacific) Pte. Ltd., an Asia Pacific Business Unit of Mitsui & Co., Ltd (Mitsui) since April 2025. He has over 26 years of working experience having served in multiple divisions in Mitsui, spanning from strategic planning, business development and operations management. He was seconded to MIMS Pte Ltd which is based in Singapore as the Chief Operating Officer from 2015 to 2018.

Prior to this, he was seconded to Parkway Pantai Limited, a wholly-owned subsidiary of IHH, as Assistant Vice President of Strategic Planning and Business Development where he led multiple business development projects from 2013 to 2015.

Mr. Nagahiro holds Bachelor of Arts in Law from University of Tokyo, Japan; Master of Business Administration from Kellogg School of Management, Northwestern University and is U.S. Certified Public Accountant.

ACADEMIC & PROFESSIONAL QUALIFICATIONS

• Bachelor of Arts in Law (concentration in Administration Law), The University of Tokyo, Japan
• U.S. Certified Public Accountant - State of Delaware, U.S.A
• Master of Business Administration, Kellogg School of Management, Northwestern University, U.S.A.

PRESENT DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS

• Director of MBK Healthcare Management Pte. Ltd.
• Non-Executive Director of IHH Healthcare Berhad
• Non-Executive Director of Tomopiia Co., Ltd.

PAST DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS HELD OVER THE PRECEDING 3 YEARS

• Co-CEO, MBK Healthcare Management Pte. Ltd.
• General Manager of Healthcare Services & Data Business Department (Wellness Business Unit), Mitsui & Co., Ltd

Age: 65

Date of appointment as a director: 17 November 2023

Date of last endorsement as a director: 30 April 2024

WORK EXPERIENCE

Dr. Prem Kumar Nair was appointed Group Chief Executive Officer of IHH Healthcare on 1 October 2023, where he leads a team of more than 70,000 employees to realise IHH's vision to be the world's most trusted healthcare services network.

Dr. Nair sets the strategic direction for the sustainable growth of IHH's global network which today comprises more than 80 hospitals in 10 countries. Guided by its Care. For Good. aspiration, Dr. Nair continues to build on the IHH portfolio of strong and reputable brands including Acibadem, Gleneagles, Fortis, Island, Mount Elizabeth, Pantai, Parkway and Prince Court - to touch lives and transform care globally.

Before his role as Group CEO, he served as CEO of IHH Singapore since 2020, where he oversaw the country's business units and played a pivotal role in strategic growth and international outreach. Prior to that, Dr. Nair was with Raffles Medical Group for 27 years, where he held concurrent roles as Chief Corporate Officer, and Managing Director for Singapore Healthcare.

With over three decades of experience as a physician and healthcare executive in both public and private sectors, Dr. Nair has earned accolades such as Wellbeing CEO at the WorkWell Leaders Award 2024 and Asia's Best CEO at the Corporate Governance Asia - Asian Excellence Award 2024 and 2025.

An active community citizen in Singapore, Dr. Nair was a recipient of the Public Service Medal (Pingat Bakti Masyarakat) in 2010 and, at the 2022 National Day Awards, he received both the Public Service Star (Bintang Bakti Masyarakat) and the Public Service Medal (PBM COVID-19), respectively, for his contributions to the Singapore Prison Service and his support of national COVID-19 efforts. He is also a Justice of the Peace and an Adjunct Associate Professor at the National University of Singapore's Saw Swee Hock School of Public Health.

ACADEMIC & PROFESSIONAL QUALIFICATIONS

• Bachelor of Medicine & Bachelor of Surgery (MBBS) - National University of Singapore
• Master of Business Administration (Distinction) - Manchester Business School, United Kingdom

PRESENT DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS

• Group CEO, IHH Healthcare
• Vice Chairman, Fortis Healthcare Limited

PAST DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS HELD OVER THE PRECEDING 3 YEARS

• Chief Executive Officer, Singapore of IHH Healthcare Berhad

Age: 66

Date of appointment as a director: 17 November 2023

Date of last endorsement as a director: 30 April 2024

WORK EXPERIENCE

Dato' Sri Muthanna Abdullah is a Barrister of Middle Temple and an Advocate and Solicitor of the High Court of Malaya. He read law at the University of Buckingham, England and was called to the Bar of England and Wales in 1982 and to the Malaysian Bar in 1983. He is a Consultant of Abdullah Chan & Co.

Dato' Sri Muthanna was appointed as the Honorary Consul to Kuala Lumpur of the Republic of San Marino on 30 March 2017. He is also a Director of IHH Healthcare Berhad, MSIG Insurance Malaysia Berhad and Apollo Food Holdings Berhad.

ACADEMIC & PROFESSIONAL QUALIFICATIONS

• Bachelor of Law, University of Buckingham, England
• Barrister-at-Law, Honourable Society of Middle Temple (England)

PRESENT DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS

• Consultant of Abdullah Chan & Co (Advocates & Solicitors)
• Chairman, Independent Non-Executive Director of MSIG Insurance (Malaysia) Bhd
• Independent Non-Executive Director of IHH Healthcare Berhad
• Independent Non-Executive Director Apollo Food Holdings Berhad

PAST DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS HELD OVER THE PRECEDING 3 YEARS

• Independent Non-Executive Director of Sapura Resources Berhad
• Independent Non-Executive Director of Digital Nasional Berhad
• Independent Non-Executive Director of Malaysia Rating Corporation Berhad
• Independent Non-Executive Director of MSM Malaysia Holdings Berhad
• Independent Non-Executive Director of Malaysian Life Reinsurance Group Berhad

Age: 51

Date of appointment as a director: 5 December 2023

Date of last endorsement as a director: 30 April 2024

WORK EXPERIENCE

As the Chief Executive Officer of IHH Singapore from 1 October 2023, Dr. Peter Chow oversees the operations and management of IHH's business units in Singapore, which includes Mount Elizabeth, Mount Elizabeth Novena, Gleneagles and Parkway East hospitals, primary healthcare group Parkway Shenton, Parkway MediCentre, as well as ancillary and education entities such as Parkway Radiology, Parkway Rehab, Parkway Cancer Centre and Parkway College.

Dr. Chow joined IHH in 2018 and was appointed as Chief Executive Officer of Mount Elizabeth Novena Hospital in 2020. Despite challenges from the Covid-19 pandemic, he led the hospital through a period of strategic development and growth, strengthening its position as a regional centre of clinical excellence. In 2022, he was awarded the Public Service Medal (Covid-19) for his healthcare leadership role during the pandemic and for supporting various national pandemic efforts in Singapore.

Dr. Chow has over 20 years of healthcare management experience spanning both public and private sectors in Singapore. Trained as a dental surgeon with the National University of Singapore, he started his career as a dental officer. Subsequently he took on different management roles including quality, training, manpower, as well as managed outpatient clinical services, giving him broad-based experience in healthcare.

Prior to IHH, he was with National Healthcare Group (NHG) during which he assumed various roles including Director of Quality & College, Director of Corporate Development & Communications and Chief Operating Officer of NHG Polyclinics.

ACADEMIC & PROFESSIONAL QUALIFICATIONS

• Bachelor of Dental Surgery - National University of Singapore
• Master of Health Science (Management) - University of Sydney, Australia

PRESENT DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS

• CEO of IHH Singapore
• Director of Gleneagles Pharmacy Pte Ltd
• Director of Parkway Hospitals Singapore Pte Ltd
• Director of Mount Elizabeth Medical Holdings Ltd
• Director of Medi-Rad Associates Ltd
• Director of Parkway Promotions Pte Ltd
• Director of Gleneagles Medical Centre Ltd
• Director of Radiology Consultants Pte Ltd
• Director of Shenton Family Medical Clinics Pte Ltd
• Director of iXchange Pte Ltd
• Director of Parkway Shenton Pte Ltd
• Director of Parkway Vietnam Holdings Pte Ltd (f.k.a. Parkway Shenton International Holdings Pte Ltd)
• Director of Parkway Investments Pte Ltd
• Director of Parkway College of Nursing & Allied Health Pte Ltd
• Director of Parkway Novena Pte Ltd
• Director of Parkway Irrawaddy Pte Ltd
• Director of Nippon Medical Care Pte Ltd
• Director of Gleneagles JPMC Sdn Bhd

PAST DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS HELD OVER THE PRECEDING 3 YEARS

• Chief Executive Officer, Mount Elizabeth Novena Hospital

Age: 60

Date of appointment as a director: 29 January 2009

Date of last re-endorsement as a director: 24 April 2023

WORK EXPERIENCE

Mr. Yong serves as the Chief Executive Officer and Executive Director of Parkway Trust Management Limited, the manager of PLife REIT.

He has led PLife REIT through a period of exceptional growth, cementing its position as a leading Asian healthcare REIT with total assets under management surpassing S$2.57 billion. Since assuming leadership, he has overseen a multi-fold expansion of the REIT's portfolio and strategic recycling - from 3 to 74 properties - while delivering unitholder value through 141.9% cumulative growth in DPU and over 390% of total return since its IPO. Under his stewardship, PLife REIT achieved a significant milestone in 2025 with its inclusion in the newly launched iEdge Singapore Next 50 Indices by SGX. This recognition highlights the REIT's strong capital discipline, robust strategic execution, and consistently solid operating performance, placing it among sizeable companies beyond the top 30 by market capitalisation. Additionally, PLife REIT's commitment to transparency, sustainability, and stakeholder engagement has been recognised with multiple awards, including the 2024 Shareholder Communications Excellence Award (SIAS Investors' Choice Awards) and the 2023 Singapore Corporate Sustainability Award for excellence in ESG practices and risk management. In 2022, PLife REIT was also named The Edge Singapore Billion Dollar Club Winner for delivering the highest returns to shareholders.

Mr. Yong's extensive expertise in finance and corporate strategy stems from his previous role as CFO of the Singapore Tourism Board, where he managed finance and corporate services. Before that, he served as CFO of Ascendas Pte Ltd, during which he was seconded to China-Singapore Suzhou Development Ltd and Singapore-Suzhou Township Development Pte Ltd as CFO in Suzhou, China. Prior to his role at Ascendas, Mr. Yong held various finance and audit positions at Beijing ISS International School, the Housing and Development Board, and Arthur Andersen.

A champion of sustainable growth, Mr. Yong's vision continues to drive PLife REIT's innovation in healthcare real estate, ensuring resilience and long-term value for stakeholders.

ACADEMIC & PROFESSIONAL QUALIFICATIONS

• B.ACC (Hons), Fellow Chartered Accountant of Singapore
• Advanced Management Programme with Harvard Business School

PRESENT DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS

• Independent Director and Audit & Risk Committee Chairman of China-Singapore Suzhou Industrial Park Development Group Co., Ltd.

PAST DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS HELD OVER THE PRECEDING 3 YEARS

• Nil